Qnovia
Richmond, US · Delaware corporation · 3 known investors
Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation. The company targets patients seeking nicotine replacement therapy in the pulmonary drug delivery and digital health space.
Founders & leadership
MD
Mario DanekinFounder
BQ
Brian QuigleyExecutive
Board
SF
Sean FaheyBoard director
BR
Brian RianoBoard director
GS
Investors · 3
Reported raises · per SEC filings
Form D private placements$41.3M disclosed across 3 rounds · 2022–2024
▶$14.2MraisedNov 2024 · 7 investors · PharmaceuticalsRule 506(b)
▶$14.2MraisedNov 2024 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mario DanekExecutive Officer, Director
- Sean FaheyDirector
- Brian QuigleyExecutive Officer, Director
- Brian RianoDirector
- Gregg SmithDirector
- Offering amount
- $16M
- Amount sold
- $14.2M
- Proceeds to insiders
- $1.6M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJun 2023 · 3 investors · BiotechnologyRule 506(b)
▶$2.9MraisedJun 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian RianoDirector
- Mario DanekExecutive Officer, Director
- Brian QuigleyExecutive Officer, Director
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $5M
- Amount sold
- $2.9M
- Proceeds to insiders
- $500K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedAug 2022 · BiotechnologyRule 506(b)
▶$24.2MraisedAug 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian QuigleyDirector
- Mario DanekDirector
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $30M
- Amount sold
- $24.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA19 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Bioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Attovia Therapeutics10 shared keywordsAttovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options. Its team includes a leadership team, board of directors, and scientific advisors experienced in drug development and company building.
Companies competing with Qnovia for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structureQnoviaDelaware
In the news
Frequently asked questions
- What does Qnovia do?
- Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation. The company targets patients seeking nicotine replacement therapy in the pulmonary drug delivery and digital health space.
- Who founded Qnovia?
- Qnovia was founded by Mario Danek.
- Who are Qnovia's investors?
- Qnovia's investors include Evolution VC Partners, Blue Ledge Capital, Vice Ventures.
- How much funding has Qnovia raised?
- Qnovia has disclosed $41.3M raised across 3 rounds.
- Where is Qnovia headquartered?
- Qnovia is headquartered in Richmond, US.